Cuts May Curb Generic Use: APhA

Published Online: Wednesday, February 1, 2006

The new pharmacist reimbursement formula established under the Medicaid program cuts passed by Congress late last year may result in reduced generic substitution by the nation's pharmacies, officials at the American Pharmacists Association (APhA) warned.

The controversial budget cuts "will likely have a disastrous impact on the profession's ability to provide necessary care to Medicaid patients,"APhA said in response to the legislation.

At the same time, however, the association suggested that the cutback may prove to be counterproductive by discouraging pharmacists from dispensing more cost-effective generic medicines. According to APhA, "the new payment formula, through an absence of incentives, could actually discourage the dispensing of generic drugs, a significant source of Medicaid savings."

Latest Articles
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.
Chronic kidney disease incidence has grown faster than many of its common comorbidities such as diabetes and hypertension, and medications may be an underappreciated driver of this growth.
President Barack Obama’s fiscal year 2017 budget proposal calls for an additional $1.1 billion to combat the nation’s spiraling opioid epidemic.
Baxter International is voluntarily recalling intravenous solution due to leaking containers and the potential for particulate matter.
Latest Issues